Iom Bioworks: Investing in the Future of Gut-Driven Healthcare

At BestVantage Investments, we believe in backing trailblazer startups that stretch the frontiers of science and technology to address health concerns in the real world. A shining example is Iom Bioworks, a Bengaluru deep science startup revolutionising healthcare through bespoke gut microbiome intelligence.

Iom Bioworks, which was established in 2022, intersects leading microbiome science with artificial intelligence and systems biology to provide personalised, data-driven dietary suggestions. The company's methodology is not just about learning one's gut profile but converting that into usable lifestyle and dietary advice.

Defensible IP and Strong Traction

In its first year, Iom Bioworks has achieved tremendous milestones. It has treated over 500 clients, received two international patents with two more in the advanced stages, and had research published in prestigious scientific journals. These are hallmarks of good execution ability and scientific depth.

Its ecosystem of products includes home gut test kits, a frictionless digital platform, and personalized food and prebiotic recommendations. With pan-India logistics and digital presence, Iom Bioworks is well-positioned to scale rapidly while staying scientifically correct.

Backed by Leading Early-Stage Investors

Iom Bioworks recently secured seed funding of INR 4 crore led by Inflection Point Ventures (IPV). IPV has invested more than INR 800 crore in 210+ startups, with a preference for startups building enduring impact in sectors. Their backing is a testament to the strong investor confidence in Iom Bioworks' scientific underpinnings, market opportunity, and execution plan.

The resources will be invested in a strategic manner to enhance IP positions, expand infrastructure, expand market presence, and expand both scientific and commercial staff—formulating the basis for long-term expansion and growth.

Positioned in a Rapidly Expanding Market

The global personalised health and wellness market is projected to reach USD 900 billion by 2030, growing at a compound annual growth rate of 28%. With rising awareness about gut health and its critical role in preventing chronic disease, improving immunity, and enhancing mental well-being, consumer interest in microbiome-based healthcare is accelerating.

Iom Bioworks is uniquely positioned to lead this shift with its personalised, AI-powered approach backed by rigorous scientific research.

A Compelling Opportunity for Investors

At BestVantage Investments, we look for startups with a scalable business model, defensible intellectual property, and a meaningful mission. With validated demand, a strong leadership team, and a platform built for scale, the companies that we endorse presents a compelling opportunity in the evolving startup landscape across various niches.

Get in touch with BestVantage Investments to find out more about the current startup landscape in India and find amazing startups to invest in.